Skip to main content
OpenTrials

Clinical trial condition

Alpha 1-Antitrypsin Deficiency

Explore clinical trials studying Alpha 1-Antitrypsin Deficiency. Study availability and eligibility vary by location and protocol.

33 public trials 5 recruiting studies
Refine in advanced search Browse all conditions

Alpha 1-Antitrypsin Deficiency trial results

Completed

Efficacy and Safety Study of Augmentation Therapy With ARALAST Fraction IV-1 (Human Alpha 1 - Proteinase Inhibitor)

NCT00396006

Conditions
Alpha 1-Antitrypsin Deficiency, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, +9 more
Locations
  • Adelaide, South Australia, Australia
  • Melbourne, Victoria, Australia
  • Nedlands, Western Australia, Australia
  • Otahuhu, Auckland, New Zealand
View Trial Details
Completed

Alpha-1 Foundation Research Registry

NCT00499941

Conditions
Alpha 1-Antitrypsin Deficiency, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, +9 more
Locations
  • Medical University of South Carolina. Division of Pulmonary and Critical Care Medicine Charleston, South Carolina, United States
View Trial Details
Completed

Efficacy/Safety of HA Inhalation Solution for Hereditary Emphysema in Patients With Alpha-1 Antitrypsin Deficiency

NCT03114020

Conditions
Alpha 1-Antitrypsin Deficiency, Chronic Disease, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +13 more
Locations
  • University of Miami Hospital Miami, Florida, United States
  • Pulmonary Health Physicians, PC Fayetteville, New York, United States
  • Medical University of South Carolina Charleston, South Carolina, United States
  • University of Texas Health Science Center Tyler, Texas, United States
View Trial Details
Completed

Comparison of Pharmacokinetic, Safety, Tolerability of Alpha-1 MP and Prolastin In Alpha1-antitrypsin Deficient Adults

NCT00295061

Conditions
Alpha 1-Antitrypsin Deficiency, Chronic Disease, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +14 more
Locations
  • National Jewish Medical and Research Center Denver, Colorado, United States
  • University of Florida College of Medicine Gainesville, Florida, United States
  • University of Miami School of Medicine Miami, Florida, United States
  • St Lukes-Roosevelt Hospital Center, New York New York, United States
View Trial Details
Completed

The Safety and Tolerability of Alpha-1 Modified Process (MP) In Subjects With Alpha-1-antitrypsin (AAT) Deficiency

NCT00301366

Conditions
Alpha 1-Antitrypsin Deficiency, Chronic Disease, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +14 more
Locations
  • National Jewish Medical and Research Center Denver, Colorado, United States
  • University of Florida College of Medicine Gainesville, Florida, United States
  • University of Miami School of Medicine Miami, Florida, United States
  • St Lukes-Roosevelt Hospital Center, New York New York, United States
View Trial Details

Related conditions